Perrigo Seeks FDA Over-The-Counter OK for Opill Birth-Control Pill
11 Juli 2022 - 12:50PM
Dow Jones News
By Colin Kellaher
Perrigo Co. on Monday said its HRA Pharma unit has filed for
U.S. Food and Drug Administration approval of what would be the
first over-the-counter birth-control pill in the U.S.
The Dublin-based healthcare company said it is seeking a switch
for its Opill, a prescription daily birth-control pill the FDA
approved in 1973, to over-the-counter status, a move Perrigo said
would help remove barriers to access to contraception.
Perrigo's move comes after the Supreme Court last month
eliminated the constitutional right to an abortion, overruling the
1973 Roe v. Wade decision and leaving the question of abortion's
legality to the states.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
July 11, 2022 06:35 ET (10:35 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Perrigo Company Plc Irel... (NYSE:PRGO)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Perrigo Company Plc Irel... (NYSE:PRGO)
Historical Stock Chart
Von Apr 2023 bis Apr 2024
